US FDA Regulators Identify Chondroitin as Contaminant in Blood-Thinner Heparin
On March 19, 2008, Reuters reported that US regulators had identified Chondroitin as the contaminant found in batches of Baxter International's recalled blood-thinner heparin.
The FDA made the discovery as part of their investigation into serious reactions and deaths.
The substance was identified as over-sulfated chondroitin sulfate, Dr. Janet Woodcock, director of the FDA's Center for Drug Evaluation and Research, told Reuters.
Chondroitin sulfate is widely sold as a dietary supplement to treat joint pain.
The over-sulfated version is not known to occur in nature and therefore likely was chemically modified, the article quoted Woodcock as saying.
The FDA recommends that physicians, dialysis center staff and health care providers use an alternate source of heparin or another blood-thinning drug when possible.
If you were harmed after being administered heparin, please complete the form below and a representative of our firm will contact you as soon as possible.
see also:
Chondroitin in Heparin
FDA Names Contaminant in Heparin: Over Sulfated Chondroitin Sulfate Regulators identify Chondroitin as contaminant in Baxter's Heparin
Oversulfated condroitin sulfate
More information on Heparin, Oversulfated Condroitin Sulfate Oversulfated Condroitin Sulfate is contaminant in Baxter's Heparin
Heparin contamination
Information on Heparin contaminationGet FREE lawsuit review about Heparin contamination
